Telstar promotes aseptic technology developments for pharma production
European Pharmaceutical Review | November 04, 2019
The Telstar portfolio also includes integrated turnkey engineering & construction services for process facilities, manufacturing plants, critical installations and laboratories, as well as GMP consultancy for regulatory compliance and IT solutions for regulated processes & logistics management. Designed to respond to Industry 4.0 challenges in the life science industry, Telstar will endorse their latest innovative smart developments in the process analytical technology field for pharmaceutical freeze-drying systems and aseptic manufacturing processes, together with integrated process equipment and laboratory integrated management systems. A selection of these technologically advanced systems is detailed below. In the freeze-drying process field, Lyogistics Zero is the only automatic vial loading & unloading system for freeze-drying processes that can be cleaned (CIP) and sterilised (SIP) in place, inside the freeze-dryer chamber. Lyonuc is the nucleation induction method developed by Telstar, suitable for any type of freeze dryer that reduces the duration of the primary drying cycle and ensures the uniformity and homogenisation of the vials in all the batches, respecting the product’s morphology and physiochemical properties. Lyomega SV is a new single-vessel GMP production freeze dryer, optimised to maintain conventional work space while making the footprint up to 20 percent smaller than a lyophiliser with standard external condenser configuration. Lyogistics Smart R3 is the new automated inline vial management device able to reject, reintroduce and retrieve vials during the loading/unloading process into pharmaceutical freeze dryers.